In fiscal year 2014-2015, California spent nearly $3.8 billion on prescription medicines, equal to the entire GDP of Malawi. A bit over 80 percent of this amount was for Medi-Cal (the Medicaid welfare program) and the Public Employees’ Retirement System (CalPERS). In California, state agencies negotiate medicine prices with manufacturers. In some situations, different state...more
Warren A. Kaplan JD, PhD is Assistant Professor of Global Health at the Boston Boston University Center for Global Health & Development. He teaches and conducts research on international and national pharmaceutical policy pharmaceutical, patient-based social networking as an “early warning” for adverse medical events, and use of mobile telephone and IT to improve adherence to medicines for diabetes, HIV, asthma and antimicrobial resistance. Dr. Kaplan has consulted for the Clinton Foundation, the World Health Organization, Doctors Without Borders, Health Action International (HAI), the Medicines Patent Pool (Geneva).